Australia's Cann Group (ASX: CAN) appears to have experienced a significant setback in its pursuit of registering an over-the-counter cannabidiol (CBD) product.A number of...
Regulatory changes were recently introduced in Western Australia for prescribing and dispensing Schedule 8 medicinal cannabis products.Products containing tetrahydrocannabinol (THC) are considered Schedule...
Another Kiwi medical cannabis company has been awarded GMP (Good Manufacturing Practice) certification.Following Helius Therapeutics' announcement in August*, Rua Bioscience has also received GMP...